Literature DB >> 12212823

Oxidative stress and hemodynamic maladjustment in chronic renal disease: a therapeutic implication.

Narisa Futrakul1, Piyaratana Tosukhowong, Yuvadee Valyapongpichit, Numdee Tipprukmas, Prasit Futrakul, Suthiluk Patumraj.   

Abstract

Hemodynamic maladjustment with predominant constriction at the efferent arteriole has been encountered in a variety of clinical settings of glomerulonephropathy. In essence, it induces not only intraglomerular hypertension but also exaggeratedly reduces the peritubular capillary flow, which supplies the tubulointerstitial compartment. The hemodynamic maladjustment is believed to reflect a glomerular endothelial cell dysfunction. In this regard, oxidative stress and antioxidant defect are likely responsible for the glomerular endothelial dysfunction. Improvement in renal function was accomplished following the correction of oxidant and antioxidant imbalance with antioxidant therapy and vasodilators. Following such therapy, there was a correction in hemodynamic maladjustment with a decline in intraglomerular hydrostatic pressure and an increase in renal perfusion with a subsequent increase in renal functions namely creatinine clearance, glomerular filtration rate and a decline in FEMg.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12212823     DOI: 10.1081/jdi-120006770

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

1.  Urgent call for reconsideration of chronic kidney disease.

Authors:  Narisa Futrakul; Prasit Futrakul
Journal:  World J Nephrol       Date:  2012-12-06

2.  Inadequate Antioxidative Responses in Kidneys of Brain-Dead Rats.

Authors:  Dane Hoeksma; Rolando A Rebolledo; Maximilia Hottenrott; Yves S Bodar; Janneke J Wiersema-Buist; Harry Van Goor; Henri G D Leuvenink
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

3.  Mitoprotection preserves the renal vasculature in porcine metabolic syndrome.

Authors:  Alfonso Eirin; Ahmad F Hedayat; Christopher M Ferguson; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Exp Physiol       Date:  2018-05-27       Impact factor: 2.969

Review 4.  Biomarker for early renal microvascular and diabetic kidney diseases.

Authors:  Narisa Futrakul; Prasit Futrakul
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

5.  Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis.

Authors:  Kirk N Campbell; Natali Pennese; Andrea Zaffalon; Barbara Magalhaes; Marina Faiella; Dawn J Caster; Jai Radhakrishnan; Vladimir Tesar; Howard Trachtman
Journal:  Kidney Med       Date:  2022-03-24

6.  Different aspects of kidney function in well-controlled congenital hypothyroidism.

Authors:  Alaleh Gheissari; Mahin Hashemipour; Pooya Khosravi; Atoosa Adibi
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.